LabSimply develops CRISPR-powered molecular diagnostics in less than 5 minutes, bringing PCR accuracy at point-of-care in Antigen testing times and costs.
EnterpriseWorks Tenure: 2021-2022
News & Milestones
- VedaBio Launches with Over $40 Million to Revolutionize Molecular Detection
- VedaBio to Revolutionize Molecular Detection (illinois.edu)
LabSimply Now
LabSimply is now known as VedaBio and continues unveiling breakthroughs through the CRISPR CascadeTM platform in San Diego, California.